(Q51301290)

3 April 2018

title

Serum level of fibroblast growth factor 23 in maintenance renal transplant patients. (English)

1 reference

3 April 2018

Ana Isabel Sanchez Fuctuoso

author

1

1 reference

3 April 2018

Cristina Fernández Pérez

12

1 reference

3 April 2018

Sara Rafael

object named as

Sara Rafael

5

0 references

Silvia Veganzones

object named as

Silvia Veganzones

6

0 references

Marta Vidaurreta

object named as

Marta Vidaurreta

11

0 references

author name string

Maria L Maestro

2

1 reference

3 April 2018

Isabel Pérez-Flores

3

1 reference

3 April 2018

Rosalía Valero

4

1 reference

3 April 2018

Natividad Calvo

7

1 reference

3 April 2018

Virginia De la Orden

8

1 reference

3 April 2018

Jose C De la Flor

9

1 reference

3 April 2018

Francisco Valga

10

1 reference

3 April 2018

Alberto Barrientos

13

1 reference

3 April 2018

language of work or name

English

0 references

publication date

1 November 2012

1 reference

3 April 2018

Nephrology Dialysis Transplantation

published in

1 reference

3 April 2018

volume

27

1 reference

3 April 2018

issue

11

1 reference

3 April 2018

page(s)

4227-4235

1 reference

3 April 2018

Post-renal transplantation hypophosphatemia: a review and novel insights

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS409

Hypercalcemia after renal transplantation. Long-term follow-up data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS409

Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS409

Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS409

Evidence for a PTH-independent humoral mechanism in post-transplant hypophosphatemia and phosphaturia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS409

How fibroblast growth factor 23 works

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS409

Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS409

The parathyroid is a target organ for FGF23 in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS409

Regulation of fibroblast growth factor-23 signaling by klotho

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS409

Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS409

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS409

Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS409

Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS409

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS409

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS409

Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS409

Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS409

The bone-renal axis in early chronic kidney disease: an emerging paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS409

1,25-dihydroxyvitamin D synthesis after renal transplantation: the role of fibroblast growth factor 23 and cyclosporine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS409

Fibroblast growth factor-23 and parathyroid hormone are associated with post-transplant bone mineral density loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS409

The relative role of fibroblast growth factor 23 and parathyroid hormone in predicting future hypophosphatemia and hypercalcemia after living donor kidney transplantation: a 1-year prospective observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS409

Tertiary excess of fibroblast growth factor 23 and hypophosphatemia following kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS409

Mineral abnormalities and long-term graft function in pediatric renal transplant recipients: a role for FGF-23?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS409

Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS409

A metabolic complication of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS409

Bone formation regulates circulating concentrations of fibroblast growth factor 23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS409

MDRD equations for estimation of GFR in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS409

Plasminogen activator inhibitor-1 deficiency has renal benefits but some adverse systemic consequences in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS409

21 January 2018

Identifiers

DOI

10.1093/NDT/GFS409

1 reference

3 April 2018

1 reference

3 April 2018